# Scientific Considerations Related to Developing Follow-On Protein Products; Correction
**AGENCY:**
Food and Drug Administration, HHS.
**ACTION:**
Notice of public workshop; correction.
**SUMMARY:**
The Food and Drug Administration (FDA) is correcting a notice that appeared in the *Federal Register* of August 16, 2004 (69 FR 50386). The document announced a public workshop on scientific and technical considerations related to the development of follow-on protein pharmaceutical products. The document was published with an inadvertent error. This document corrects that error.
**FOR FURTHER INFORMATION CONTACT:**
Joyce Strong, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-7010.
In FR Doc. 04-18627 appearing on page 50386 in the issue of August 16, 2004, the following correction is made: On page 50386, in the third column, under the heading *ADDRESSES* , in the second paragraph add a new second sentence to read: Submit electronic comments to *http://www.fda.gov/dockets/ecomments* .
Dated: August 31, 2004.
William K. Hubbard,
Associate Commissioner for Policy and Planning.